Previous Close | 0.0290 |
Open | 0.0280 |
Bid | 0.0280 x 25215400 |
Ask | 0.0290 x 5549800 |
Day's Range | 0.0270 - 0.0290 |
52 Week Range | 0.0170 - 0.0480 |
Volume | |
Avg. Volume | 2,816,953 |
Market Cap | 14.381M |
Beta (5Y Monthly) | 0.72 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0100 |
Earnings Date | Feb 27, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
Key Insights AdAlta's Annual General Meeting to take place on 22nd of November Salary of AU$324.9k is part of CEO Tim...
Melbourne, Australia--(Newsfile Corp. - August 16, 2023) - AdAlta Limited (ASX: 1AD), the clinical stage drug discovery company developing novel therapeutic products from its i-body platform, today announced that its CEO and Managing Director, Dr Tim Oldham, would be presenting at the Virtual Investor Summit on 24 August, hosted by Investor Summit Group.During his presentation at the Summit, Dr Oldham will describe the products that AdAlta is developing to treat challenging diseases such as ...